Durham, NC, United States of America

Thomas Petersen

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Setauket, NY (US) (2019 - 2023)
  • Durham, NC (US) (2018 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Thomas Petersen: Innovator in Pulmonary and Vascular Treatments

Introduction

Thomas Petersen is a distinguished inventor based in Durham, NC (US), known for his significant contributions to the field of medical treatments. With a total of 13 patents to his name, he has focused on innovative solutions for pulmonary arterial hypertension and vasculopathy.

Latest Patents

Among his latest patents is a method for treating pulmonary arterial hypertension (PAH) using prostacyclin-treated endothelial progenitor cells. This application outlines a process that involves isolating endothelial progenitor cells (EPCs), treating them with prostacyclin, and administering the treated EPCs to patients suffering from PAH. Another notable patent addresses the treatment of vasculopathy, which includes methods for administering prostacyclin alongside mesenchymal stem cells (MSCs) or MSC-conditioned culture mediums. These pharmaceutical compositions are designed to enhance treatment outcomes for patients in need.

Career Highlights

Throughout his career, Thomas Petersen has worked with prominent organizations such as United Therapeutics Corporation and Yale University. His work in these institutions has allowed him to advance his research and develop groundbreaking treatments that have the potential to improve patient care significantly.

Collaborations

Thomas has collaborated with notable colleagues, including Roger Jeffs and Roger M Ilagan. These partnerships have contributed to the success of his innovative projects and have fostered a collaborative environment for research and development.

Conclusion

Thomas Petersen's work exemplifies the impact of innovation in the medical field, particularly in treating complex conditions like pulmonary arterial hypertension and vasculopathy. His patents and collaborations reflect a commitment to advancing healthcare through scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…